Vtama sales 2025?

I can help with that, but a couple of clarifications will help me give you something useful:

- Do you mean Vtama (the dermatology brand) for tapinarof? If yes, are you looking for the US market or global sales, and do you want reported numbers or a forecast?
- Do you want a simple forecast model you can populate (with scenarios), or a summary of current publicly available estimates if any?

I don’t have live 2025 sales data here, and I can’t pull current numbers in real time. But I can help you build a forecast or point you to the right sources. Here’s a practical way to approach it:

How to forecast Vtama sales for 2025 (framework you can use)
- Define scope
- Region(s): US only or global
- Currency and year (2025)
- Include net sales, or gross sales minus rebates/discounts (net)
- Market and demand drivers
- Indication coverage (plaque psoriasis, etc.)
- Target patient population size by region
- Treatment penetration and uptake rate (how quickly clinicians switch or start using Vtama)
- Competition (other topicals, biologics, generics, new entrants)
- Reimbursement environment and access
- Pricing and volume assumptions
- List price and expected net price after rebates/discounts
- Estimated treated patient count and average utilization per patient (e.g., annual courses, duration)
- Uptake curve
- Year 0 (launch year): initial penetration
- Year 1–2: ramp-up assumptions
- Year 3+: plateau or continued growth (include potential label expansions)
- Regional adjustments
- Different launch timelines, payer dynamics, and uptake in each region
- Risk and sensitivity

- Build a simple model (illustrative)
- For each region, estimate:
- Treated patients (US: X; EU: Y)
- Net price per patient per year (US: $Z; EU: $W)
- Market share/penetration (0–100%)
- Sales = Treated patients × Net price × Penetration
- Sum across regions for total 2025 sales
- Create scenarios (base, optimistic, downside) by adjusting penetration and price

If you want, tell me:
- US vs global
- Whether you want a quick rough range or a detailed scenario-based forecast
- Any known factors (e.g., recent FDA actions, competitor launches, or label expansions)

I can then draft a simple forecast template with placeholders and example scenarios you can fill in, or summarize where to find the latest numbers from investor materials and market reports.